Low-dose vs. standard-dose alteplase for acute ischemic stroke: a retrospective cohort study of safety and efficacy in an Iranian population
Abstract Background The optimal dosing of alteplase for acute ischemic stroke remains debated, particularly regarding the balance between efficacy and bleeding risks. This study compared outcomes between standard-dose (0.9 mg/kg) and low-dose (< 0.85 mg/kg) alteplase in an Iranian cohort. Methods In...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2025-09-01
|
| Seri Bilgileri: | BMC Neurology |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s12883-025-04413-z |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|